Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry.

Clinical trial Drug eluting stent Human Percutaneous coronary intervention Risk factor

Journal

International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 24 12 2023
revised: 04 02 2024
accepted: 19 02 2024
medline: 17 4 2024
pubmed: 17 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs): hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs. Patients with an indication for a PCI were stratified based upon the number of SMuRFs: 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year. Inverse weighted propensity score (IWPS) adjustment was performed to adjust for differences in baseline characteristics. The prevalence of SMuRFs was: 0 SMuRF 16.4 %; 1 SMuRF 27.8 %; 2 SMuRFs 34.7 % and 3-4 SMuRFs 21.1 %. Patients without SMuRFs were younger, more likely to be male and had less complex coronary artery disease. The incidence of TLF increased with the number of SMuRFs: 2.65 %, 2.75 %, 3.23 %, and 4.24 %, P The incidence of clinical events at 1-year increased with the number of SMuRFs. While patients without SMuRFs have a relatively favourable risk profile, more research is needed to optimize therapeutic management in the majority of patients.

Identifiants

pubmed: 38628296
doi: 10.1016/j.ijcha.2024.101370
pii: S2352-9067(24)00036-8
pmc: PMC11018637
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101370

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ofer Kobo (O)

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Yaniv Levi (Y)

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Rami Abu-Fanne (R)

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Clemens Von Birgelen (C)

Thoraxcentrum Twente, Medisch Spectrum Twente, and Department Health Technology and Services Research, University of Twente, Enschede, The Netherlands.

Antoine Guédès (A)

CHU UCL Namur, Site de Mont Godinne, Université catholique de Louvain, Belgium.

Adel Aminian (A)

Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.

Peep Laanmets (P)

North Estonia Medical Center Foundation, Tallinn, Estonia.

Willem Dewilde (W)

Imelda Hospital, Bonheiden, Belgium.

Adam Witkowski (A)

Institute of Cardiology, Warsaw, Poland.

Jacques Monsegu (J)

Institut Cardio-Vasculaire, Groupe Hospitalier Mutualiste, Grenoble, France.

Andres Romo Iniguez (A)

Hospital Álvaro Cunqueiro, Vigo, Spain.

Majdi Halabi (M)

Ziv Medical Center, Zfat, Israel.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, Keele, Newcastle, United Kingdom.

Ariel Roguin (A)

Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Classifications MeSH